6 Colo. Code Regs. § 1007-1-24.13
Current through Register Vol. 47, No. 11, June 10, 2024
Section 6 CCR 1007-1-24.13 - Electronic Brachytherapy24.13.1 Electronic brachytherapy devices shall be subject to the requirements of 24.13, and shall be exempt for the requirements of 24.7. 24.13.1.1 An electronic brachytherapy device that does not meet the requirements of 24.13 shall not be used for irradiation of patients; and24.13.1.2 An electronic brachytherapy device shall only be utilized for human use applications specifically approved by the U.S. Food and Drug Administration (FDA) unless participating in a research study approved by the registrant's Institutional Review Board (IRB).24.13.2 Each facility location authorized to use an electronic brachytherapy device in accordance with 24.13 shall possess portable radiation monitoring equipment in accord with 24.11 that is operable and calibrated in accordance with 24.12 for the applicable electronic brachytherapy source energy.24.13.3 In addition to shielding adequate to meet requirements of 24.4.5, the treatment room shall meet the following design requirements:24.13.3.1 If applicable, provision shall be made to prevent simultaneous operation of more than one therapeutic radiation machine in a treatment room.24.13.3.2 Access to the treatment room shall be controlled by a door at each entrance.24.13.3.3 Each treatment room shall have provisions to permit continuous aural communication and visual observation of the human patient from the treatment control panel during irradiation. The electronic brachytherapy device shall not be used for human patient irradiation unless the patient can be observed.24.13.3.4 For electronic brachytherapy devices capable of operating below 50 kV, radiation shielding for the staff in the treatment room shall be available, either as a portable shield and/or as localized shielded material around the treatment site.24.13.3.5 For electronic brachytherapy devices capable of operating at greater than 150 kV: (1) The control panel shall be located outside the treatment room; and(2) Electrical interlocks shall be provided for all door(s) to the treatment room that will:(a) Prevent the operator from initiating the treatment cycle unless each treatment room entrance door is closed;(b) Cause the source to be shielded when an entrance door is opened; and(c) Prevent the source from being exposed following an interlock interruption until all treatment room entrance doors are closed and the source on-off control is reset at the console.24.13.4 Electrical Safety for Electronic Brachytherapy Devices. 24.13.4.1 The high voltage transformer shall be electrically isolated to prevent electrical and magnetic interference with the surrounding environment and ancillary equipment.24.13.4.2 The high voltage transformer shall be isolated from personnel (e.g., operator) and the environment by a protective housing that can only be accessed through a cover requiring a tool for access or with electrical interlocks to prevent operation while open.24.13.4.3 The high voltage transformer shall have appropriate safety labels warning personnel of potential electrical shock and/or heat related injuries.24.13.4.4 Equipment manufactured after shall be in compliance with the most current revision of the following International Electrotechnical Commission (IEC) Documents: (1) IEC 60601-1:1998+A1+A2:1995;(3) IEC 60601-2-8:1999; and24.13.5 The control panel, in addition to the displays required by other provisions in 24.13, shall: 24.13.5.1 Provide an indication of whether electrical power is available at the control panel and if activation of the electronic brachytherapy source is possible;24.13.5.2 Provide an indication of whether x rays are being produced;24.13.5.3 Provide a means for indicating electronic brachytherapy source potential and current;24.13.5.4 Provide the means for terminating an exposure at any time; and24.13.5.5 Include an access control (locking) device that will prevent unauthorized use of the electronic brachytherapy device.24.13.6 A suitable irradiation control device (timer) shall be provided to terminate the irradiation after a pre-set time interval or integrated charge on a dosimeter-based monitor.24.13.6.1 A timer shall be provided at the treatment control panel and shall indicate planned setting and the time elapsed or remaining;24.13.6.2 The timer shall not permit an exposure if set at zero;24.13.6.3 The timer shall be a cumulative device that activates with an indication of "BEAM-ON" and retains its reading after irradiation is interrupted or terminated. After irradiation is terminated and before irradiation can be reinitiated, it shall be necessary to reset the elapsed time indicator;24.13.6.4 The timer shall terminate irradiation when a pre-selected time has elapsed, if any dose monitoring system has not previously terminated irradiation.24.13.6.5 The timer shall permit setting of exposure times as short as 0.1 second; and24.13.6.6 The timer shall be accurate to within one (1) percent of the selected value or 0.1 second, whichever is greater.24.13.7 Registered Medical Physicist Support. 24.13.7.1 In each facility having an electronic brachytherapy device, a Registered Medical Physicist shall be responsible for:(1) Evaluation of the output from the electronic brachytherapy source;(2) Generation of the necessary dosimetric information;(3) Supervision and review of treatment calculations prior to initial treatment of any treatment site;(4) Establishing the periodic and day-of-use quality assurance checks and reviewing the data from those checks as required in 24.13.11;(5) Consultation with the authorized user in treatment planning, as needed; and(6) Performing calculations/assessments regarding patient treatments that may constitute a reportable medical event as provided in 24.6.3.24.13.7.2 The operating procedures required by 24.13.8 shall specify how the Registered Medical Physicist is to be contacted for problems or emergencies, as well as the specific actions, if any, to be taken until the Registered Medical Physicist is contacted.24.13.8 Operating Procedures. 24.13.8.1 Only individuals approved by the authorized user, Radiation Safety Officer, or Registered Medical Physicist shall be present in the treatment room during treatment;24.13.8.2 Electronic brachytherapy devices shall not be made available for medical use unless the requirements of 24.4.1, 24.13.9 and 24.13.10 have been met;24.13.8.3 The electronic brachytherapy device shall be inoperable, either by hardware or password, when unattended by qualified staff or service personnel;24.13.8.4 During operation, the electronic brachytherapy device operator shall monitor the position of all persons in the treatment room, and all persons entering the treatment room, to prevent entering persons from unshielded exposure from the treatment beam; (1) The electronic brachytherapy device shall not be used for human patient irradiation unless the patient can be observed as provided in 24.13.3.3.24.13.8.5 If a patient must be held in position during treatment, mechanical supporting or restraining devices shall be used;24.13.8.6 Written procedures shall be developed, implemented, and maintained for responding to an abnormal situation, including:(1) Instructions for responding to equipment failures and the names of the individuals responsible for implementing corrective actions; and(2) The names and telephone numbers of the authorized users, the Registered Medical Physicist, and the Radiation Safety Officer to be contacted if the device or console operates abnormally.24.13.8.7 A copy of the current operating and emergency procedures shall be physically located at the electronic brachytherapy device control console; (1) If the control console is integral to the electronic brachytherapy device, the required procedures shall be kept where the operator is located during device operation;24.13.8.8 Instructions shall be posted at the electronic brachytherapy device control console to inform the operator of the names and telephone numbers of the authorized users, the Registered Medical Physicist, and the Radiation Safety Officer to be contacted if the device or console operates abnormally; (1) If the control console is integral to the electronic brachytherapy device, the required procedures shall be kept where the operator is located during device operation; and24.13.8.9 If the patient has a medical emergency, suffers injury or dies, the Radiation Safety Officer, or RSO's designee, and an authorized user shall be notified as soon as possible but no later than 48 hours after the event.24.13.9 Safety Precautions for Electronic Brachytherapy Devices.24.13.9.1 A Registered Medical Physicist shall determine which persons in the treatment room require monitoring when the beam is energized;24.13.9.2 An authorized user and a Registered Medical Physicist shall be physically present during the initiation of all human patient treatments involving the electronic brachytherapy device;24.13.9.3 A Registered Medical Physicist and either an authorized user or a physician or electronic brachytherapy device operator, under the personal supervision of an authorized user, who has been trained in the operation and emergency response for the electronic brachytherapy device, shall be physically present during continuation of all human patient treatments involving the electronic brachytherapy device;24.13.9.4 When shielding is required by 24.13.3.4, the electronic brachytherapy device operator shall use a survey meter to verify proper placement of the shielding immediately upon initiation of treatment. Alternatively, a Registered Medical Physicist shall designate shield locations sufficient to meet the requirements of Part 4 of these regulations for any individual, other than the patient, in the treatment room; and24.13.9.5 All personnel in the treatment room are required to remain behind shielding during treatment. A Registered Medical Physicist shall approve any deviation from this requirement and shall designate alternative radiation safety protocols, compatible with patient safety, to provide an equivalent degree of protection.24.13.10 Electronic Brachytherapy Source Calibration Measurements. 24.13.10.1 Calibration of the electronic brachytherapy source output for an electronic brachytherapy device subject to 24.13 shall be performed by, or under the direct supervision of, a Registered Medical Physicist;24.13.10.2 Calibration of the electronic brachytherapy source output shall be made for each electronic brachytherapy source, or after any repair affecting the x-ray beam generation, or when indicated by the electronic brachytherapy source quality assurance checks;24.13.10.3 Calibration of the electronic brachytherapy source output shall utilize a dosimetry system described in 24.4.3.24.13.10.4 Calibration of the electronic brachytherapy source output shall include, as applicable, determination of:(1) The output within two percent (2%) of the expected value, if applicable, or determination of the output if there is no expected value;(2) Timer accuracy and linearity over the typical range of use;(3) Proper operation of back-up exposure control devices;(4) Evaluation that the relative dose distribution about the source is within five percent (5%) of that expected; and(5) Source positioning accuracy to within one (1) millimeter within the applicator;24.13.10.5 Calibration of the x-ray source output required by 24.13.10.1 through 24.13.10.4 shall be in accordance with current published recommendations from a recognized national professional association with expertise in electronic brachytherapy (when available). In the absence of a calibration protocol published by a national professional association, the manufacturer's calibration protocol shall be followed.24.13.10.6 The registrant shall maintain a record of each calibration in an auditable form for the duration of the registration, including the: (1) Date of the calibration;(2) Manufacturer's name, model number and serial number for the electronic brachytherapy device;(3) Unique identifier for the corresponding electronic brachytherapy source;(4) Model numbers and serial numbers of the instrument(s) used to calibrate the electronic brachytherapy device; and(5) Name and signature of the Registered Medical Physicist responsible for performing the calibration.24.13.11 Periodic and Day-of-Use Quality Assurance Checks for Electronic Brachytherapy Devices. 24.13.11.1 Quality assurance checks shall be performed on each electronic brachytherapy device subject to 24.13: (1) At the beginning of each day of use;(2) Each time the device is moved to a new room or site; and(3) After each x-ray tube installation.24.13.11.2 The registrant shall perform periodic quality assurance checks required by 24.13.11.1 in accordance with procedures established by the Registered Medical Physicist;24.13.11.3 To satisfy the requirements of 24.13.11.1, radiation output quality assurance checks shall include as a minimum:(1) Verification that output of the electronic brachytherapy source falls within three percent (3%) of expected values, as appropriate for the device, as determined by: (a) Output as a function of time, or(b) Output as a function of setting on a monitor chamber.(2) Verification of the consistency of the dose distribution to within three percent (3%) of that found during calibration required by 24.13.10.; and(3) Validation of the operation of positioning methods to ensure that the treatment dose exposes the intended location within one (1) mm; and24.13.11.4 The registrant shall use a dosimetry system that meets the requirements of 24.4.3 to make the quality assurance checks required in 24.13.11.3.24.13.11.5 The registrant shall review the results of each radiation output quality assurance check according to the following procedures:(1) An authorized user and Registered Medical Physicist shall be immediately notified if any parameter is not within its acceptable tolerance. The electronic brachytherapy device shall not be made available for subsequent medical use until the Registered Medical Physicist has determined that all parameters are within their acceptable tolerances;(2) If all radiation output quality assurance check parameters appear to be within their acceptable range, the quality assurance check shall be reviewed and signed by either the authorized user or Registered Medical Physicist within two (2) days; and(3) The Registered Medical Physicist shall review and sign the results of each radiation output quality assurance check at intervals not to exceed thirty (30) days.24.13.11.6 To satisfy the requirements of 24.13.11.1 safety device quality assurance checks shall, at a minimum, assure:(1) Proper operation of radiation exposure indicator lights on the electronic brachytherapy device and on the control console;(2) Proper operation of viewing and intercom systems in each electronic brachytherapy facility, if applicable;(3) Proper operation of radiation monitors, if applicable;(4) The integrity of all cables, catheters or parts of the device that carry high voltages; and(5) Connecting guide tubes, transfer tubes, transfer-tube-applicator interfaces, and treatment spacers are free from any defects that interfere with proper operation.24.13.11.7 If the results of the safety device quality assurance checks required in 24.13.11.6 indicate the malfunction of any system, a registrant shall secure the control console in the OFF position and not use the electronic brachytherapy device except as may be necessary to repair, replace, or check the malfunctioning system.24.13.11.8 The registrant shall maintain a record of each quality assurance check required by 24.13.11.3 and 24.13.11.7 in an auditable form for three (3) years.(1) The record shall include the date of the quality assurance check; the manufacturer's name, model number and serial number for the electronic brachytherapy device; the name and signature of the individual who performed the periodic quality assurance check and the name and signature of the Registered Medical Physicist who reviewed the quality assurance check;(2) For radiation output quality assurance checks required by 24.13.11.3, the record shall also include the unique identifier for the electronic brachytherapy source and the manufacturer's name; model number and serial number for the instrument(s) used to measure the radiation output of the electronic brachytherapy device.24.13.12 Acceptance Testing For Electronic Brachytherapy.24.13.12.1 The registrant shall perform acceptance testing on the treatment planning system of electronic brachytherapy-related computer systems in accordance with current published recommendations from a recognized national professional association with expertise in electronic brachytherapy (when available). (1) In the absence of an acceptance testing protocol published by a national professional association, the manufacturer's acceptance testing protocol shall be followed.24.13.12.2 Acceptance testing shall be performed by, or under the direct supervision of, a Registered Medical Physicist and shall include at a minimum, as applicable, verification of: (1) The source-specific input parameters required by the dose calculation algorithm;(2) The accuracy of dose, dwell time, and treatment time calculations at representative points;(3) The accuracy of isodose plots and graphic displays;(4) The accuracy of the software used to determine radiation source positions from radiographic images; and(5) The accuracy of electronic transfer of the treatment delivery parameters to the treatment delivery unit from the treatment planning system, if the treatment-planning system is different from the treatment-delivery system.24.13.12.3 The position indicators in the applicator shall be compared to the actual position of the source or planned dwell positions, as appropriate, at the time of commissioning.24.13.12.4 Prior to each patient treatment regimen, the parameters for the treatment shall be evaluated and approved by the authorized user and the Registered Medical Physicist for correctness through means independent of that used for the determination of the parameters.24.13.13 Mobile Electronic Brachytherapy.24.13.13.1 A registrant providing mobile electronic brachytherapy service shall, as a minimum:(1) Check all survey instruments before medical use at each address of use or on each day of use, whichever is more restrictive.(2) Account for the electronic brachytherapy source in the electronic brachytherapy device before departure from the client's address.(3) Perform, at each location on each day of use, all of the required quality assurance checks specified in 24.13.11 to assure proper operation of the device.24.13.14 Training. 24.13.14.1 A registrant shall provide instruction, initially and at least annually, to all individuals who operate the electronic brachytherapy device, as appropriate to the individual's assigned duties, in the operating procedures identified in 24.13.8. If the interval between patients exceeds one year, retraining of the individuals shall be provided.24.13.14.2. In addition to the requirements of 24.3.3 for therapeutic radiation machine authorized users and 24.3.4 for Registered Medical Physicists, these individuals shall also receive device-specific instruction initially from the manufacturer, and annually from either the manufacturer or other qualified trainer. The training shall be of a duration recommended by a recognized national professional association with expertise in electronic brachytherapy (when available). In the absence of any training protocol recommended by a national professional association, the manufacturer's training protocol shall be followed. The training shall include, but not be limited to: (1) Device-specific radiation safety requirements;(3) Clinical use for the types of use approved by the FDA;(4) Emergency procedures, including an emergency drill; and(5) The registrant's Quality Assurance Program.24.13.14.3. A registrant shall retain a record of individuals receiving instruction required by 24.13.14 for three (3) years. The record shall include a list of the topics covered, the date of the instruction, the name(s) of the attendee(s), and the name(s) of the individual(s) who provided the instruction.Colorado Register, Vol 37, No. 14. July 25, 2014, effective 8/14/201438 CR 02, January 25, 2015, effective 2/14/201538 CR 05, March 10, 2015, effective 3/30/201538 CR 12, June 25, 2015, effective 7/15/201538 CR 14, July 25, 2015, effective 8/14/201539 CR 02, January 25, 2016, effective 2/14/201639 CR 16, August 25, 2016, effective 9/14/201639 CR 22, November 25, 2016, effective 12/15/201640 CR 11, June 10, 2017, effective 6/30/201740 CR 20, October 25, 2017, effective 11/14/201742 CR 24, December 25, 2019, effective 1/14/202043 CR 14, July 25, 2020, effective 8/14/202043 CR 18, September 25, 2020, effective 10/15/202044 CR 11, June 10, 2021, effective 7/15/202144 CR 14, July 25, 2021, effective 8/14/202145 CR 22, November 25, 2022, effective 12/15/2022